Astrantus’s HCA Healthcare HCA Stock Holding History

Astrantus’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,456	Closed	-$631K	–	229
2021 Q4	$631K	Buy	+2,456	New	+$601K	0.47%	88

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Astrantus's HCA Position: Q1 2022 in Review

Astrantus sold out of HCA Healthcare (HCA) in Q1 2022, closing a stake of 2,456 shares — an estimated $631K sold.

Astrantus first reported a position in HCA in Q4 2021 and held it in 1 quarter. The position peaked at $631K in Q4 2021. 968 funds tracked by Wall St. Rank hold HCA as of Q1 2022.

Astrantus reported no remaining HCA Healthcare position as of Q1 2022 after selling out during the quarter.
Astrantus sold 2,456 HCA Healthcare shares in Q1 2022, an estimated $631K.
Astrantus first reported a position in HCA Healthcare in Q4 2021 and held it in 1 quarter.
Astrantus's HCA Healthcare position peaked at $631K in Q4 2021.
968 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.